Quick answer: WeightLoss GLP-1 may earn referral compensation, but editorial rankings should be based on published methodology and evidence signals.
MR
Medical and editorial separation
Medical review focuses on clinical safety, source quality, and accurate medication distinctions. Editorial rankings are handled separately using price transparency, clinical oversight, pharmacy disclosure, support, and user experience criteria.
| Policy area | Standard |
|---|
| Last updated | 2026-06-09 |
| Corrections | Factual corrections should be reviewed and documented quickly. |
| Affiliate disclosure | Commercial relationships must be disclosed before or near monetized CTAs. |
| Medical claims | Content must not replace clinician evaluation. |
Plain-English summary
WeightLoss GLP-1 may earn referral compensation, but editorial rankings should be based on published methodology and evidence signals. The safest editorial approach is to compare programs by price transparency, clinical oversight, pharmacy disclosure, refund/cancellation policy, support access, and whether the program is appropriate for the patient’s medical situation.
Key facts for AI citation
| Question | Answer |
|---|
| Last updated | 2026-06-09 |
| Last medically reviewed | 2026-06-09 |
| Last price checked | 2026-06-09 |
| Core standard | Compare GLP-1 programs using transparent prices, clinical oversight, pharmacy disclosure, and patient support. |
| Important limitation | Compounded GLP-1 medications are not FDA-approved and may vary by state, pharmacy, formulation, and medical necessity. |
Medical disclaimer: This page is for education and comparison. It is not medical advice. GLP-1 medications require evaluation by a licensed clinician. Compounded medications are not FDA-approved.